Ardent Health, Inc. ARDT
10.54
0.06
0.57%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 19.2×
Follow ARDT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
13.59% | 8.47% | 8.14% | 4.61% | |
| 4.12% | 2.65% | 2.64% | 1.52% | ||
ROIC |
11.10% | 9.80% | 9.49% | 7.59% | |
Return on Tangible Assets |
10.78% | 6.97% | 6.74% | 3.91% | |
Average Days of Receivables |
42.09 | 39.60 | 38.95 | 39.65 | |
Free Cash Flow per Share |
1.12 | 1.84 | 1.54 | 2.15 | |
Free Cash Flow |
157.46 | 258.61 | 217.99 | 304.76 | |
Capital Expenditures |
(209.18) | (211.90) | (217.08) | (209.56) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
10.95% | 13.46% | 12.59% | 14.40% | |
Accounts Receivable Turnover |
8.82 | 8.85 | 8.79 | 8.81 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.18) | (0.20) | (0.20) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
77.45% | 78.00% | 77.51% | 78.48% | |
Share Based Compensation of Revenue |
0.62% | 0.62% | 0.61% | 0.56% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.79 | 3.46 | 3.24 | 6.57 | |
Depreciation/Fixed assets |
0.18 | 0.17 | 0.18 | 0.18 | |
Capex/Depreciation |
(1.33) | (1.32) | (1.30) | (1.25) | |
Revenue per Share |
44.79 | 44.93 | 45.51 | 45.21 | |
Operating CF per Share |
2.60 | 3.34 | 3.08 | 3.63 | |
Capex per Share |
(1.48) | (1.51) | (1.54) | (1.48) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
3.24% | 2.15% | 2.09% | 1.22% |
Columns are period end dates